Atlas Trials

Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux

Clinical trial NCT00369265 · TERMINATED

Trial details

NCT number
NCT00369265
Sponsor
American Institute for Voice and Ear Research
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Laryngopharyngeal Reflux
Start date
2006-08-01
Primary completion
2009-11-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.